Due to their unique physicochemical properties, graphene-family nanomaterials (GFNs) are
widely used in many fields, especially in biomedical applications. Currently, many studies …

Personalized cancer vaccines (PCVs) are reinvigorating vaccine strategies in cancer
immunotherapy. In contrast to adoptive T-cell therapy and checkpoint blockade, the PCV …

Messenger RNA (mRNA) vaccine is a promising candidate in cancer immunotherapy as it
can encode tumor-associated antigens with an excellent safety profile. Unfortunately, the …

Cancer remains one of the major health problems all over the world and conventional
therapeutic approaches have failed to attain an effective cure. Tumor microenvironments …

Nanoscale materials have been explored extensively as agents for therapeutic and
diagnostic (ie, theranostic) applications. Research efforts have shifted from exploring new …

The sustained extensive research on graphene and its derivatives in the last decade
portrayed its significance in the field of material science and carved its own niche in …

Cancer immunotherapies such as tumor vaccines, chimeric antigen receptor T cells and
immune checkpoint blockades, have attracted tremendous attention. Among them, tumor …

Vaccine is one of the most effective strategies for preventing and controlling infectious
diseases and some noninfectious diseases, especially cancers. Adjuvants and carriers have …

Abstract Two-dimensional (2D) nanomaterials hold great potential in cancer application. At
present, the research of 2D nanomaterials mainly focuses on elucidating their unique …

Graphene-based nanomaterials, such as graphene oxide and reduced graphene oxide,
have been attracting increasing attention in the field of biology and biomedicine over the …